GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (XSWX:SHLTN) » Definitions » EV-to-Revenue

SHL Telemedicine (XSWX:SHLTN) EV-to-Revenue : 1.33 (As of May. 16, 2024)


View and export this data going back to 2000. Start your Free Trial

What is SHL Telemedicine EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SHL Telemedicine's enterprise value is CHF66.98 Mil. SHL Telemedicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF50.39 Mil. Therefore, SHL Telemedicine's EV-to-Revenue for today is 1.33.

The historical rank and industry rank for SHL Telemedicine's EV-to-Revenue or its related term are showing as below:

XSWX:SHLTN' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.04   Med: 2.39   Max: 5.99
Current: 1.33

During the past 13 years, the highest EV-to-Revenue of SHL Telemedicine was 5.99. The lowest was 1.04. And the median was 2.39.

XSWX:SHLTN's EV-to-Revenue is ranked better than
69.14% of 661 companies
in the Healthcare Providers & Services industry
Industry Median: 1.87 vs XSWX:SHLTN: 1.33

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), SHL Telemedicine's stock price is CHF4.44. SHL Telemedicine's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF3.10. Therefore, SHL Telemedicine's PS Ratio for today is 1.43.


SHL Telemedicine EV-to-Revenue Historical Data

The historical data trend for SHL Telemedicine's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine EV-to-Revenue Chart

SHL Telemedicine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 3.60 6.15 4.15 2.25

SHL Telemedicine Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.15 - 4.15 - 2.25

Competitive Comparison of SHL Telemedicine's EV-to-Revenue

For the Health Information Services subindustry, SHL Telemedicine's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's EV-to-Revenue falls into.



SHL Telemedicine EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

SHL Telemedicine's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=66.982/50.391
=1.33

SHL Telemedicine's current Enterprise Value is CHF66.98 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF50.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SHL Telemedicine  (XSWX:SHLTN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

SHL Telemedicine's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.44/3.098
=1.43

SHL Telemedicine's share price for today is CHF4.44.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was CHF3.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SHL Telemedicine EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SHL Telemedicine (XSWX:SHLTN) Business Description

Traded in Other Exchanges
Address
90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.

SHL Telemedicine (XSWX:SHLTN) Headlines

No Headlines